Nephros, Inc. (NASDAQ:NEPH) Short Interest Update

Nephros, Inc. (NASDAQ:NEPH) was the recipient of a large increase in short interest in March. As of March 15th, there was short interest totalling 19,400 shares, an increase of 133.7% from the February 28th total of 8,300 shares. Based on an average daily volume of 13,500 shares, the days-to-cover ratio is presently 1.4 days. Currently, 0.2% of the company’s stock are short sold.

Nephros Price Performance

Nephros stock remained flat at $1.67 during mid-day trading on Friday. 8,180 shares of the company were exchanged, compared to its average volume of 12,835. The company’s 50 day moving average price is $1.57 and its 200-day moving average price is $1.57. Nephros has a 52 week low of $1.36 and a 52 week high of $2.55. The firm has a market cap of $17.61 million, a P/E ratio of -18.56 and a beta of 1.19.

Nephros (NASDAQ:NEPH) last announced its quarterly earnings results on Monday, March 24th. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.04. Nephros had a negative return on equity of 11.39% and a negative net margin of 6.86%. The business had revenue of $3.87 million for the quarter, compared to the consensus estimate of $3.67 million.

Institutional Investors Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Topline Capital Management LLC acquired a new position in Nephros, Inc. (NASDAQ:NEPH) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 419,887 shares of the company’s stock, valued at approximately $617,000. Topline Capital Management LLC owned 3.98% of Nephros as of its most recent filing with the Securities & Exchange Commission. 41.10% of the stock is currently owned by institutional investors and hedge funds.

About Nephros

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.